Prostate cancer is a serious health issue for many men. Doctors often use a method called active surveillance to monitor it. This means they keep a close eye on the cancer instead of treating it right away. But how do they decide who is a good fit for this approach? One tool that might help is the
Chronic myeloid leukemia, or CML, is a blood cancer that's defined by a specific genetic change. Doctors have been using drugs that target this change, called tyrosine kinase inhibitors, to treat CML. These drugs have been a game-changer, but some patients don't respond well and their condition wors
Rare conditions might affect a small group of people, but they collectively impact around 300 million globally. In the past, early diagnosis was challenging due to the failure to recognize rare conditions and order the right genomic tests. However, advancements in genome sequencing now offer a faste
